We are live on ! Find out more
BIP

Brandes Investment Partners Portfolio holdings

AUM $14.1B
1-Year Est. Return 25.52%
This Fund
S&P 500
This Quarter Est. Return
+27.93%
1 Year Est. Return
+25.52%
3 Year Est. Return
+82.74%
5 Year Est. Return
+120.97%
10 Year Est. Return
+869.55%
AUM
$3.88B
AUM Growth
+$989M
Cap. Flow
+$233M
Cap. Flow %
6.01%
Top 10 Hldgs %
35.46%
Holding
161
New
11
Increased
69
Reduced
67
Closed
12

Top Sells

Rank Stock Value
1
CX icon
Cemex
CX
+$48.9M
2
BIDU icon
Baidu
BIDU
+$24.4M
3
FDX icon
FedEx
FDX
+$22.6M
4
HAL icon
Halliburton
HAL
+$19.6M
5
NXPI icon
NXP Semiconductors
NXPI
+$18.8M

Sector Composition

Rank Sector Weight
1 Financials 22.57%
2 Healthcare 17.58%
3 Industrials 13.77%
4 Energy 9.97%
5 Materials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPP icon
51
WPP
WPP
$5.81B
$23.7M 0.61%
434,888
-25,390
-6% -$1.2M
E icon
52
ENI
E
$79.7B
$23.4M 0.6%
1,120,406
-58,992
-5% -$1.07M
HP icon
53
Helmerich & Payne
HP
$4.29B
$23.1M 0.6%
980,558
+272,547
+38% +$5.28M
ENIC icon
54
Enel Chile
ENIC
$6.07B
$22.5M 0.58%
5,745,819
-128,032
-2% -$457K
TTE icon
55
TotalEnergies
TTE
$194B
$22.5M 0.58%
526,453
-28,277
-5% -$1.09M
CYD icon
56
China Yuchai International
CYD
$1.77B
$22.3M 0.57%
1,372,258
-72,104
-5% -$1.26M
BP icon
57
BP
BP
$110B
$21.4M 0.55%
1,018,447
+23,059
+2% +$435K
HMC icon
58
Honda
HMC
$40.6B
$21.1M 0.54%
748,952
+1,408
+0.2% +$38K
AVDL
59
DELISTED
Avadel Pharmaceuticals
AVDL
$19.8M 0.51%
2,961,878
+121,209
+4% +$758K
TMHC
60
DELISTED
Taylor Morrison
TMHC
$19.5M 0.5%
737,195
-39,274
-5% -$1M
KOF icon
61
Coca-Cola Femsa
KOF
$23.1B
$19.1M 0.49%
408,361
+46,520
+13% +$2.03M
PBR.A icon
62
Petrobras Class A
PBR.A
$103B
$19M 0.49%
1,728,804
+8,588
+0.5% +$75.1K
ACWX icon
63
iShares MSCI ACWI ex US ETF
ACWX
$12B
$17M 0.44%
318,136
-107,182
-25% -$5.32M
CRH icon
64
CRH
CRH
$65.3B
$16.5M 0.42%
384,400
-11,294
-3% -$444K
ANAT
65
DELISTED
American National Group, Inc. Common Stock
ANAT
$16.3M 0.42%
170,625
+24,947
+17% +$2.01M
BCS icon
66
Barclays
BCS
$94.6B
$15M 0.39%
1,863,478
-35,357
-2% -$237K
ABEV icon
67
Ambev
ABEV
$43.8B
$14.9M 0.39%
4,900,287
+42,605
+0.9% +$115K
CHL
68
DELISTED
China Mobile Limited
CHL
$13.5M 0.35%
476,862
-101,352
-18% -$3.13M
BUD icon
69
AB InBev
BUD
$156B
$13.3M 0.34%
187,577
-24,061
-11% -$1.52M
NVS icon
70
Novartis
NVS
$290B
$13.2M 0.34%
+139,611
New +$12.2M
PKX icon
71
POSCO
PKX
$17.3B
$13M 0.34%
209,120
-10,487
-5% -$557K
GRFS
72
Grifois
GRFS
$5.4B
$12.5M 0.32%
+674,685
New +$12.5M
EGRX
73
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$12.3M 0.32%
264,397
+109,473
+71% +$5.12M
MUFG icon
74
Mitsubishi UFJ Financial
MUFG
$257B
$12.2M 0.31%
2,749,857
-112,277
-4% -$477K
NOK icon
75
Nokia
NOK
$57.4B
$10.8M 0.28%
2,780,756
-120,486
-4% -$474K

Similar funds

Brandes Investment Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Brandes Investment Partners held 161 positions worth $3.88B, up 34% from $2.89B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Brandes Investment Partners deployed $233M of net new capital in Q4 2020, opening 11 new positions and adding to 69 existing holdings. Its largest new stake was Grifois: 674,685 shares worth $12.5M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Cemex, an estimated $48.9M trimmed.

  • Brandes Investment Partners's largest Q4 2020 buy was Grifois: 674,685 shares worth $12.5M.
  • Brandes Investment Partners added most to UBS Group in Q4 2020, an estimated $200M increase.
  • Brandes Investment Partners's biggest Q4 2020 reduction was Cemex, cutting an estimated $48.9M.
  • Brandes Investment Partners fully exited NXP Semiconductors in Q4 2020, selling an estimated $18.8M.
  • Brandes Investment Partners's ten largest holdings make up 35% of its $3.88B portfolio in Q4 2020.
  • Brandes Investment Partners opened 11 new positions and closed 12 in Q4 2020.
  • Brandes Investment Partners's portfolio value rose 34% quarter-over-quarter to $3.88B.

Based on Brandes Investment Partners's 13F filing for Q4 2020, filed 11 Feb 2021.